Haemophilus influenzae and the complement system

被引:64
作者
Hallstrom, Teresia [1 ,2 ]
Riesbeck, Kristian [1 ]
机构
[1] Lund Univ, Skane Univ Hosp, Dept Lab Med Malmo, SE-20502 Malmo, Sweden
[2] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Infect Biol, Jena, Germany
基金
英国医学研究理事会;
关键词
B CAPSULE EXPRESSION; SERUM RESISTANCE; SIALIC-ACID; OUTER-MEMBRANE; OTITIS-MEDIA; PROTEIN E; C4B-BINDING PROTEIN; RESPIRATORY-TRACT; FACTOR-H; LIPOPOLYSACCHARIDE;
D O I
10.1016/j.tim.2010.03.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The respiratory tract pathogen Haemophilus influenzae is responsible for a variety of infections in humans including septicemia, bronchitis, pneumonia, and acute otitis media. The pathogenesis of H. influenzae relies on its capacity to resist human host defenses including the complement system, and thus H. influenzae has developed several efficient strategies to circumvent complement attack. In addition to attracting specific host complement regulators directly to the bacterial surface, the capsule, lipooligosaccharides, and several outer membrane proteins contribute to resistance against complement-mediated attacks and hence increased bacterial survival. Insights into the mechanisms of complement evasion by H. influenzae are important for understanding pathogenesis and for developing vaccines and new therapies aimed at patients with, for example, chronic obstructive pulmonary disease. Here we overview current knowledge on the different mechanisms by which H. influenzae evades attack by the host complement system.
引用
收藏
页码:258 / 265
页数:8
相关论文
共 74 条
[1]   Invasive serotype a Haemophilus influenzae infections with a virulence genotype resembling Haemophilus influenzae type b:: Emerging pathogen in the vaccine era? [J].
Adderson, EE ;
Byington, CL ;
Spencer, L ;
Kimball, A ;
Hindiyeh, M ;
Carroll, K ;
Mottice, S ;
Korgenski, EK ;
Christenson, JC ;
Pavia, AT .
PEDIATRICS, 2001, 108 (01) :E18
[2]   Novel sialic acid transporter of Haemophilus influenzae [J].
Allen, S ;
Zaleski, A ;
Johnston, JW ;
Gibson, BW ;
Apicella, MA .
INFECTION AND IMMUNITY, 2005, 73 (09) :5291-5300
[3]   COMPLEMENT ACTIVATION ON THE NASAL MUCOSAL SURFACE - A FEATURE OF THE IMMEDIATE ALLERGIC REACTION IN THE NOSE [J].
ANDERSSON, M ;
MICHEL, L ;
LLULL, JB ;
PIPKORN, U .
ALLERGY, 1994, 49 (04) :242-245
[4]   Emergence of nonencapsulated and encapsulated non-b-type invasive Haemophilus influenzae isolates in Portugal (1989-2001) [J].
Bajanca, P ;
Caniça, M .
JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (02) :807-810
[5]   COMPLEMENT IS ACTIVATED IN THE UPPER RESPIRATORY-TRACT DURING INFLUENZA-VIRUS INFECTION [J].
BJORNSON, AB ;
MELLENCAMP, MA ;
SCHIFF, GM .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 143 (05) :1062-1066
[6]   Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media [J].
Block, SL ;
Hedrick, J ;
Harrison, CJ ;
Tyler, R ;
Smith, A ;
Findlay, R ;
Keegan, E .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2004, 23 (09) :829-833
[7]   Complement inhibitor C4b-binding protein -: friend or foe in the innate immune system? [J].
Blom, AM ;
Villoutreix, BO ;
Dahlbäck, B .
MOLECULAR IMMUNOLOGY, 2004, 40 (18) :1333-1346
[8]   Complement evasion strategies of pathogens-Acquisition of inhibitors and beyond [J].
Blom, Anna M. ;
Hallstrom, Teresia ;
Riesbeck, Kristian .
MOLECULAR IMMUNOLOGY, 2009, 46 (14) :2808-2817
[9]   Host-derived sialic acid is incorporated into Haemophilus influenzae lipopolysaccharide and is a major virulence factor in experimental otitis media [J].
Bouchet, V ;
Hood, DW ;
Li, JJ ;
Brisson, JR ;
Randle, GA ;
Martin, A ;
Li, Z ;
Goldstein, R ;
Schweda, EKH ;
Pelton, SI ;
Richards, JC ;
Moxon, ER .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (15) :8898-8903
[10]   Invasive Haemophilus influenzae Disease Caused by Non-Type b Strains in Northwestern Ontario, Canada, 2002-2008 [J].
Brown, Veronica M. ;
Madden, Sharen ;
Kelly, Len ;
Jamieson, Frances B. ;
Tsang, Raymond S. W. ;
Ulanova, Marina .
CLINICAL INFECTIOUS DISEASES, 2009, 49 (08) :1240-1243